{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:55:21Z","timestamp":1765356921490},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ygeno.2021.04.014","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T01:46:57Z","timestamp":1618969617000},"page":"1647-1658","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Potential functions of hsa-miR-155-5p and core genes in chronic myeloid leukemia and emerging role in human cancer: A joint bioinformatics analysis"],"prefix":"10.1016","volume":"113","author":[{"given":"Ismael","family":"Soltani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Bahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahlem","family":"Farrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelkarim","family":"Mahdhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima","family":"Ferchichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ygeno.2021.04.014_bb0010","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.20062335","article-title":"Oncogenic signaling: New insights and controversies from chronic myeloid leukemia","volume":"204","author":"Van Etten","year":"2007","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.ygeno.2021.04.014_bb0020","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2011-08-358135","article-title":"Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: A single-institution historical experience","volume":"119","author":"Kantarjian","year":"2012","journal-title":"Blood"},{"issue":"5531","key":"10.1016\/j.ygeno.2021.04.014_bb0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to sti-571 cancer therapy caused by bcr-abl gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2010-12-326405","article-title":"Bcr-abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of european leukemianet","volume":"118","author":"Soverini","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ygeno.2021.04.014_bb0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microrna biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.ygeno.2021.04.014_bb0040","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.18632\/oncotarget.14264","article-title":"Microrna 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase","volume":"8","author":"Bayraktar","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ygeno.2021.04.014_bb0045","doi-asserted-by":"crossref","first-page":"20145","DOI":"10.18632\/oncotarget.15525","article-title":"Exosomal mir-940 maintains src-mediated oncogenic activity in cancer cells: A possible role for exosomal disposal of tumor suppressor mirnas","volume":"8","author":"Rashed","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ygeno.2021.04.014_bb0050","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.18632\/oncotarget.12343","article-title":"Mirnas in acute myeloid leukemia","volume":"8","author":"Liao","year":"2017","journal-title":"Oncotarget"},{"issue":"252","key":"10.1016\/j.ygeno.2021.04.014_bb0055","article-title":"Mirna-mediated deregulation in leukemia","volume":"3","author":"Dell\u2019aversana","year":"2012","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.ygeno.2021.04.014_bb0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2217\/fon-2018-0741","article-title":"Differential expression profiles and functional analysis of plasma mirnas associated with chronic myeloid leukemia phases","volume":"15","author":"Zhang","year":"2019","journal-title":"Future Oncol."},{"issue":"6","key":"10.1016\/j.ygeno.2021.04.014_bb0065","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/10428194.2016.1243676","article-title":"Mirnas in chronic myeloid leukemia: small molecules, essential function","volume":"58","author":"Litwinska","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.ygeno.2021.04.014_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10245332.2016.1252020","article-title":"Downregulation of mir-451 in tunisian chronic myeloid leukemia patients: Potential implication in imatinib resistance","volume":"22","author":"Soltani","year":"2017","journal-title":"Hematology"},{"issue":"2\u20133","key":"10.1016\/j.ygeno.2021.04.014_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10142-016-0520-1","article-title":"Regulatory network analysis of micrornas and genes in imatinib-resistant chronic myeloid leukemia","volume":"17","author":"Soltani","year":"2017","journal-title":"Funct Integr Genomics"},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/0008-5472.CAN-14-2331","article-title":"Host mir155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ygeno.2021.04.014_bb0085","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1073\/pnas.0610983104","article-title":"Cd34+ hematopoietic stem-progenitor cell microrna expression and function: A circuit diagram of differentiation control","volume":"104","author":"Georgantas","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2007.10.077","article-title":"Expression patterns of micrornas 155 and 451 during normal human erythropoiesis","volume":"364","author":"Masaki","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.ygeno.2021.04.014_bb0095","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1093\/nar\/gkq337","article-title":"Hoxa9 regulates mir-155 in hematopoietic cells","volume":"38","author":"Hu","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ygeno.2021.04.014_bb0100","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of mir-155 and bic rna in human b cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.ygeno.2021.04.014_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"Bic and mir-155 are highly expressed in hodgkin, primary mediastinal and diffuse large b cell lymphomas","volume":"207","author":"Kluiver","year":"2005","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0110","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.22800","article-title":"Microrna expression distinguishes between germinal center b cell-like and activated b cell-like subtypes of diffuse large b cell lymphoma","volume":"121","author":"Lawrie","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0115","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"Micrornas in b-cell lymphomas: how a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bjh.12157","article-title":"Micrornas and lymphomagenesis: a functional review","volume":"160","author":"Lawrie","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"79","key":"10.1016\/j.ygeno.2021.04.014_bb0125","article-title":"Microrna-155 as an inducer of apoptosis and cell differentiation in acute myeloid leukaemia","volume":"13","author":"Palma","year":"2014","journal-title":"Mol. Cancer"},{"issue":"9513037","key":"10.1016\/j.ygeno.2021.04.014_bb0130","article-title":"Mir-155 as a biomarker in b-cell malignancies","volume":"2016","author":"Due","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"11","key":"10.1016\/j.ygeno.2021.04.014_bb0135","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1158\/1078-0432.CCR-16-1025","article-title":"Combining anti-mir-155 with chemotherapy for the treatment of lung cancers","volume":"23","author":"Van Roosbroeck","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"7043","key":"10.1016\/j.ygeno.2021.04.014_bb0140","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"Microrna expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.leukres.2005.09.001","article-title":"Hematopoietic-specific microrna expression in human cells","volume":"30","author":"Ramkissoon","year":"2006","journal-title":"Leuk. Res."},{"issue":"10","key":"10.1016\/j.ygeno.2021.04.014_bb0150","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","article-title":"Expression of the mir-17-92 polycistron in chronic myeloid leukemia (cml) cd34+ cells","volume":"109","author":"Venturini","year":"2007","journal-title":"Blood"},{"issue":"402","key":"10.1016\/j.ygeno.2021.04.014_bb0155","article-title":"Overview of microrna biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Database issue","key":"10.1016\/j.ygeno.2021.04.014_bb0160","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"Mirbase: Annotating high confidence micrornas using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"Web Server issue","key":"10.1016\/j.ygeno.2021.04.014_bb0165","doi-asserted-by":"crossref","first-page":"W70","DOI":"10.1093\/nar\/gkn188","article-title":"The vienna rna websuite","volume":"36","author":"Gruber","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.ygeno.2021.04.014_bb0170","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1093\/nar\/gkw116","article-title":"Distribution of mirna expression across human tissues","volume":"44","author":"Ludwig","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ygeno.2021.04.014_bb0175","doi-asserted-by":"crossref","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","article-title":"Mirtarbase update 2018: A resource for experimentally validated microrna-target interactions","volume":"46","author":"Chou","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.ygeno.2021.04.014_bb0180","doi-asserted-by":"crossref","first-page":"D105","DOI":"10.1093\/nar\/gkn851","article-title":"Mirecords: An integrated resource for microrna-target interactions","volume":"37","author":"Xiao","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ygeno.2021.04.014_bb0185","doi-asserted-by":"crossref","first-page":"D90","DOI":"10.1093\/nar\/gkw926","article-title":"Mirpathdb: A new dictionary on micrornas and target pathways","volume":"45","author":"Backes","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ygeno.2021.04.014_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206239","article-title":"Mirwalk: An online resource for prediction of microrna binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PLoS One"},{"issue":"Web Server issue","key":"10.1016\/j.ygeno.2021.04.014_bb0195","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkt393","article-title":"Diana-microt web server v5.0: Service integration into mirna functional analysis workflows","volume":"41","author":"Paraskevopoulou","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.ygeno.2021.04.014_bb0200","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"Starbase v2.0: Decoding mirna-cerna, mirna-ncrna and protein-rna interaction networks from large-scale clip-seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ygeno.2021.04.014_bb0205","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/ijms17040564","article-title":"Mirtargetlink--mirnas, genes and interaction networks","volume":"17","author":"Hamberg","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ygeno.2021.04.014_bb0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using david bioinformatics resources","volume":"4","author":"da Huang","year":"2009","journal-title":"Nat. Protoc."},{"issue":"128","key":"10.1016\/j.ygeno.2021.04.014_bb0215","article-title":"Enrichr: Interactive and collaborative html5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0220","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","article-title":"Cluepedia cytoscape plugin: Pathway insights using integrated experimental and in silico data","volume":"29","author":"Bindea","year":"2013","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.ygeno.2021.04.014_bb0225","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"Cluego: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygeno.2021.04.014_bb0230","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microrna target sites in mammalian mrnas","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"issue":"D1","key":"10.1016\/j.ygeno.2021.04.014_bb0235","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"String v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygeno.2021.04.014_bb0240","article-title":"Biological network exploration with cytoscape 3","volume":"47","author":"Su","year":"2014","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"2","key":"10.1016\/j.ygeno.2021.04.014_bb0245","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0250","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cbio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"18","key":"10.1016\/j.ygeno.2021.04.014_bb0255","article-title":"Prognoscan: A new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med. Genet."},{"issue":"1 24 21-19","key":"10.1016\/j.ygeno.2021.04.014_bb0260","article-title":"Malacards: a comprehensive automatically-mined database of human diseases","volume":"47","author":"Rappaport","year":"2014","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"26","key":"10.1016\/j.ygeno.2021.04.014_bb0265","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1182\/blood-2010-04-280156","article-title":"Mir-155 and its star-form partner mir-155* cooperatively regulate type i interferon production by human plasmacytoid dendritic cells","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ygeno.2021.04.014_bb0270","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/glia.21233","article-title":"Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory mir-155 and mir-155*","volume":"59","author":"Tarassishin","year":"2011","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.ygeno.2021.04.014_bb0275","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbagrm.2008.03.001","article-title":"Microrna-206: The skeletal muscle-specific myomir","volume":"1779","author":"JJ","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0280","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/gb-2004-5-3-r13","article-title":"Expression profiling of mammalian micrornas uncovers a subset of brain-expressed micrornas with possible roles in murine and human neuronal differentiation","volume":"5","author":"Sempere","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.ygeno.2021.04.014_bb0285","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-016-5413-3","article-title":"Potential role of wnt\/beta-catenin signaling in blastic transformation of chronic myeloid leukemia: Cross talk between beta-catenin and bcr-abl","author":"Hu","year":"2016","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0290","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/leu.2012.331","article-title":"Cbl-b is required for leukemogenesis mediated by bcr-abl through negative regulation of bone marrow homing","volume":"27","author":"Badger-Brown","year":"2013","journal-title":"Leukemia"},{"issue":"27","key":"10.1016\/j.ygeno.2021.04.014_bb0295","doi-asserted-by":"crossref","first-page":"42683","DOI":"10.18632\/oncotarget.7977","article-title":"Micrornas mediated regulation of mapk signaling pathways in chronic myeloid leukemia","volume":"7","author":"Chakraborty","year":"2016","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.ygeno.2021.04.014_bb0300","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/bioinformatics\/btp565","article-title":"Lost in translation: an assessment and perspective for computational microrna target identification","volume":"25","author":"Alexiou","year":"2009","journal-title":"Bioinformatics"},{"issue":"47","key":"10.1016\/j.ygeno.2021.04.014_bb0305","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","article-title":"Jak2 is involved in c-myc induction by bcr-abl","volume":"21","author":"Xie","year":"2002","journal-title":"Oncogene"},{"issue":"18","key":"10.1016\/j.ygeno.2021.04.014_bb0310","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1158\/0008-5472.CAN-13-1318","article-title":"Kit signaling governs differential sensitivity of mature and primitive cml progenitors to tyrosine kinase inhibitors","volume":"73","author":"Corbin","year":"2013","journal-title":"Cancer Res."},{"issue":"26","key":"10.1016\/j.ygeno.2021.04.014_bb0315","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in vivo microrna-155 (mir-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0320","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1755-148X.2011.00857.x","article-title":"Microrna-155 targets the ski gene in human melanoma cell lines","volume":"24","author":"Levati","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"10.1016\/j.ygeno.2021.04.014_bb0325","first-page":"1960","article-title":"Microrna-155 is downregulated in gastric cancer cells and involved in cell metastasis","volume":"27","author":"Li","year":"2012","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.ygeno.2021.04.014_bb0330","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.febslet.2013.03.023","article-title":"Microrna-155 is a novel suppressor of ovarian cancer-initiating cells that targets cldn1","volume":"587","author":"Qin","year":"2013","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.ygeno.2021.04.014_bb0335","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1007\/s11033-013-2512-8","article-title":"The prevalence and prognostic significance of kras mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer","volume":"40","author":"Ouerhani","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0340","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/leu.2012.316","article-title":"Differential roles of kras and pten in murine leukemogenesis","volume":"27","author":"Tang","year":"2013","journal-title":"Leukemia"},{"issue":"150960","key":"10.1016\/j.ygeno.2021.04.014_bb0345","article-title":"Clinical relevance of kras in human cancers","volume":"2010","author":"Jancik","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0350","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of cd34(+) hematopoietic stem and progenitor cells of patients with cml in chronic phase","volume":"21","author":"Diaz-Blanco","year":"2007","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.ygeno.2021.04.014_bb0355","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/0008-5472.CAN-12-3955","article-title":"Differential contributions of stat5a and stat5b to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem\/progenitor cells","volume":"73","author":"Casetti","year":"2013","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0360","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A cerna hypothesis: The rosetta stone of a hidden rna language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ygeno.2021.04.014_bb0365","article-title":"Downregulation of mir-31, mir-155, and mir-564 in chronic myeloid leukemia cells","volume":"7","author":"Rokah","year":"2012","journal-title":"PLoS One"},{"issue":"45","key":"10.1016\/j.ygeno.2021.04.014_bb0370","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of ph+ leukemia in mice","volume":"103","author":"Hu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.ygeno.2021.04.014_bb0375","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15171\/bi.2017.14","article-title":"Mir-155 effectively induces apoptosis in k562 philadelphia positive cell line through upregulation of p27kip1","volume":"7","author":"Edalati Fathabad","year":"2017","journal-title":"Bioimpacts"},{"issue":"478","key":"10.1016\/j.ygeno.2021.04.014_bb0380","article-title":"Bioinformatics analysis of prognostic mirna signature and potential critical genes in colon cancer","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Genet."},{"issue":"31","key":"10.1016\/j.ygeno.2021.04.014_bb0385","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021186","article-title":"Bioinformatics analysis of microrna profiles and identification of microrna-mrna network and biological markers in intracranial aneurysm","volume":"99","author":"Zhao","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1 Pt 2","key":"10.1016\/j.ygeno.2021.04.014_bb0390","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ygeno.2020.10.007","article-title":"Comprehensive in-silico analysis of damage associated snps in hoct1 affecting imatinib response in chronic myeloid leukemia","volume":"113","author":"Soltani","year":"2021","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.ygeno.2021.04.014_bb0395","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13046-017-0602-5","article-title":"Mir-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting smad4: Validation by bioinformatics and experimental analyses","volume":"36","author":"Jiang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0400","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20072108","article-title":"Sustained expression of microrna-155 in hematopoietic stem cells causes a myeloproliferative disorder","volume":"205","author":"O\u2019Connell","year":"2008","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.ygeno.2021.04.014_bb0405","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microrna expression atlas based on small rna library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ygeno.2021.04.014_bb0410","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/stem.1748","article-title":"The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by foxo transcription factors","volume":"32","author":"Pellicano","year":"2014","journal-title":"Stem Cells"},{"issue":"19","key":"10.1016\/j.ygeno.2021.04.014_bb0415","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood-2013-02-485607","article-title":"Autocrine tnf-alpha production supports cml stem and progenitor cell survival and enhances their proliferation","volume":"122","author":"Gallipoli","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ygeno.2021.04.014_bb0420","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.18632\/oncotarget.14015","article-title":"Micrornas as regulators and mediators of forkhead box transcription factors function in human cancers","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"2324709619832322","key":"10.1016\/j.ygeno.2021.04.014_bb0425","article-title":"Concurrent jak2-positive myeloproliferative disorder and chronic myelogenous leukemia: A novel entity? A case report with review of the literature","volume":"7","author":"Bader","year":"2019","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"3","key":"10.1016\/j.ygeno.2021.04.014_bb0430","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ccr.2013.01.025","article-title":"Regulation of c-myc ubiquitination controls chronic myelogenous leukemia initiation and progression","volume":"23","author":"Reavie","year":"2013","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ygeno.2021.04.014_bb0435","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.18632\/oncotarget.3074","article-title":"Long-term treatment with imatinib results in profound mast cell deficiency in ph+ chronic myeloid leukemia","volume":"6","author":"Cerny-Reiterer","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ygeno.2021.04.014_bb0440","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10555-017-9724-7","article-title":"Mir-155 in cancer drug resistance and as target for mirna-based therapeutics","volume":"37","author":"Bayraktar","year":"2018","journal-title":"Cancer Metastasis Rev."},{"issue":"11","key":"10.1016\/j.ygeno.2021.04.014_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078028","article-title":"Comprehensive analysis of single nucleotide polymorphisms in human micrornas","volume":"8","author":"Han","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ygeno.2021.04.014_bb0450","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170019","article-title":"Snps in microrna target sites and their potential role in human disease","volume":"7","author":"Moszynska","year":"2017","journal-title":"Open Biol."},{"issue":"12","key":"10.1016\/j.ygeno.2021.04.014_bb0455","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/leu.2008.124","article-title":"An activating kras mutation in imatinib-resistant chronic myeloid leukemia","volume":"22","author":"Agarwal","year":"2008","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.ygeno.2021.04.014_bb0460","doi-asserted-by":"crossref","first-page":"27216","DOI":"10.18632\/oncotarget.16111","article-title":"Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ygeno.2021.04.014_bb0465","doi-asserted-by":"crossref","first-page":"176","DOI":"10.18632\/oncotarget.6128","article-title":"Oncogenomic portals for the visualization and analysis of genome-wide cancer data","volume":"7","author":"Klonowska","year":"2016","journal-title":"Oncotarget"}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754321001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754321001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T21:51:27Z","timestamp":1726091487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754321001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0888754321001403"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2021.04.014","relation":{},"ISSN":["0888-7543"],"issn-type":[{"type":"print","value":"0888-7543"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential functions of hsa-miR-155-5p and core genes in chronic myeloid leukemia and emerging role in human cancer: A joint bioinformatics analysis","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2021.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}